Jayashri Kulkarni

Prof. Jayashri Kulkarni


Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2020 in Australasian Psychiatry
Verified
Journal Article
Open access
PDF file
HDHannah Dobson
Hannah Dobson
CMCharles B Malpas
Charles B Malpas
ABAidan Jc Burrell
Aidan Jc Burrell
CGCaroline Gurvich
Caroline Gurvich
LCLeo Chen
Leo Chen
TWTobias Winton-Brown
Tobias Winton-Brown
Objective: To examine psychological distress in healthcare workers (HCWs) during the COVID-19 pandemic in April–May 2020. Methods: A cross-sectional survey examining demographic, employment and mental health characteristics of HCWs in a large metropolitan hospital in Australia. Results: HCWs showed significant symptoms of moderate-severe level depression (21%), anxiety (20%) and posttraumatic stress disorder (PTSD; 29%), associated with burnout, prior psychiatric history, profession and resilience. Conclusion: Despite low levels of COVID contact, moderate to high levels of psychological distress were reported. Continued monitoring and support for HCWs’ mental well-being is warranted as the COVID-19 pandemic develops.

28 August 2018 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Caroline GurvichCaroline Gurvich
Caroline Gurvich
KHKate Hoy
Kate Hoy
Natalie ThomasNatalie Thomas
Natalie Thomas
JKJayashri Kulkarni
Jayashri Kulkarni
Hormones of the hypothalamic-pituitary-gonadal (HPG) axis that regulate reproductive function have multiple effects on the development, maintenance and function of the brain. Sex differences in cognitive functioning have been reported in both health and disease, which may be partly attributed to sex hormones. The aim of the current paper was to provide a theoretical review of how sex hormones influence cognitive functioning across the lifespan as well as provide an overview of the literature on sex differences and the role of sex hormones in cognitive decline, specifically in relation to Alzheimer’s disease (AD). A summary of current hormone and sex-based interventions for enhancing cognitive functioning and/or reducing the risk of Alzheimer’s disease is also provided.

16 June 2021 in Journal of Medical Internet Research
Verified
Journal Article
Open access
FBFrancesca Beilharz
Francesca Beilharz
SSSuku Sukunesan
Suku Sukunesan
SRSusan L Rossell
Susan L Rossell
JKJayashri Kulkarni
Jayashri Kulkarni
GSGemma Sharp
Gemma Sharp
Background: Body image and eating disorders represent a significant public health concern; however, many affected individuals never access appropriate treatment. Conversational agents or chatbots reflect a unique opportunity to target those affected online by providing psychoeducation and coping skills, thus filling the gap in service provision. Objective: A world-first body image chatbot called “KIT” was designed. The aim of this study was to assess preliminary acceptability and feasibility via the collection of qualitative feedback from young people and parents/carers regarding the content, structure, and design of the chatbot, in accordance with an agile methodology strategy. The chatbot was developed in collaboration with Australia’s national eating disorder support organization, the Butterfly Foundation. Methods: A conversation decision tree was designed that offered psychoeducational information on body image and eating disorders, as well as evidence-based coping strategies. A version of KIT was built as a research prototype to deliver these conversations. Six focus groups were conducted using online semistructured interviews to seek feedback on the KIT prototype. This included four groups of people seeking help for themselves (n=17; age 13-18 years) and two groups of parents/carers (n=8; age 46-57 years). Participants provided feedback on the cartoon chatbot character design, as well as the content, structure, and design of the chatbot webchat. Results: Thematic analyses identified the following three main themes from the six focus groups: (1) chatbot character and design, (2) content presentation, and (3) flow. Overall, the participants provided positive feedback regarding KIT, with both young people and parents/carers generally providing similar reflections. The participants approved of KIT’s character and engagement. Specific suggestions were made regarding the brevity and tone to increase KIT’s interactivity. Conclusions: Focus groups provided overall positive qualitative feedback regarding the content, structure, and design of the body image chatbot. Incorporating the feedback of lived experience from both individuals and parents/carers allowed the refinement of KIT in the development phase as per an iterative agile methodology. Further research is required to evaluate KIT’s efficacy.

9 September 2017 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
JGJasmin Grigg
Jasmin Grigg
RWRoisin Worsley
Roisin Worsley
CTCaroline Thew
Caroline Thew
Caroline GurvichCaroline Gurvich
Caroline Gurvich
Natalie ThomasNatalie Thomas
Natalie Thomas
JKJayashri Kulkarni
Jayashri Kulkarni

1 September 2010 in Psychoneuroendocrinology
Verified
Journal Article
Closed access
JKJayashri Kulkarni
Jayashri Kulkarni
Caroline GurvichCaroline Gurvich
Caroline Gurvich
SLStuart J. Lee
Stuart J. Lee
HGHeather Gilbert
Heather Gilbert
EGEmmy Gavrilidis
Emmy Gavrilidis
SDSusan R. Davis
Susan R. Davis

30 July 2022 in Drugs & Aging
Verified
Journal Article
Open access
PDF file
MHMegan Herson
Megan Herson
JKJayashri Kulkarni
Jayashri Kulkarni
Perimenopause marks the transition from a woman’s reproductive stage to menopause. Usually occurring between 42 and 52 years of age, it is determined clinically by the onset of irregular menstrual cycles or variable cycle lengths. Women are at an increased risk of depression and anxiety during perimenopause and the menopausal transition. Depressive symptoms experienced in perimenopause are often more severe compared to pre- and post-menopause. During menopausal transition, the impact of fluctuating estrogen in the central nervous system (CNS) can have negative psychological effects for some women. Traditional first-line management of menopausal depression involves antidepressants, with modest outcomes. The positive effects of estrogen treatment in the CNS are becoming increasingly recognised, and hormonal therapy (HT) with estrogen may have a role in the treatment of menopausal depression. In this review we will outline the prevalence, impact and neurochemical basis of menopausal-associated depression, as well as hormone-based approaches that have increasing promise as effective treatments.